drugset / Trial / NCT04747054
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
RandomizedParallel-groupOpen-labelTreatment
Summary
Study to evaluate the efficacy of treatment by radiotherapy and pembrolizumab in newly diagnosed metastatic head \& neck cancers
Timeline
- Start
- 2021-12-01
- Primary completion
- 2025-10-01
- Completion
- 2029-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 5 unknown | — |
| Subject | Cisplatin | Other / unclassified | 100 mg/m2 | — |
| Subject | Pembrolizumab | Monoclonal antibody | 200 mg | — |
| Subject | fluorouracil | Small molecule | 1000 mg/m2 | — |